DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,038,778 | -16.5% | 115,935 | +4.9% | 0.00% | – |
| Q2 2023 | $1,243,845 | +41.7% | 110,564 | +45.1% | 0.00% | – |
| Q1 2023 | $878,043 | -2.9% | 76,219 | -2.3% | 0.00% | – |
| Q4 2022 | $904,484 | -13.5% | 78,040 | -5.3% | 0.00% | – |
| Q3 2022 | $1,046,000 | +60.2% | 82,420 | -13.3% | 0.00% | – |
| Q2 2022 | $653,000 | -28.8% | 95,113 | 0.0% | 0.00% | – |
| Q1 2022 | $917,000 | -95.6% | 95,113 | -94.6% | 0.00% | -100.0% |
| Q4 2021 | $20,963,000 | -48.3% | 1,763,053 | -29.3% | 0.00% | -57.1% |
| Q3 2021 | $40,524,000 | -51.9% | 2,495,387 | -37.7% | 0.01% | -50.0% |
| Q2 2021 | $84,317,000 | +43.2% | 4,007,432 | +5.7% | 0.01% | +40.0% |
| Q1 2021 | $58,871,000 | -2.4% | 3,790,777 | +30.5% | 0.01% | -9.1% |
| Q4 2020 | $60,315,000 | +21.0% | 2,904,722 | +14.2% | 0.01% | +10.0% |
| Q3 2020 | $49,861,000 | – | 2,542,760 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $19,891,505 | 30.79% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $44,363,675 | 23.76% |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $88,573,623 | 13.72% |
| Logos Global Management LP | 2,180,000 | $19,532,800 | 2.61% |
| TCG Crossover Management, LLC | 1,650,150 | $14,785,344 | 2.18% |
| VR Adviser, LLC | 2,173,913 | $19,478,260 | 2.05% |
| Altium Capital Management LP | 315,000 | $2,822,400 | 1.47% |
| Vivo Capital, LLC | 1,035,136 | $9,274,819 | 1.02% |
| Octagon Capital Advisors LP | 692,945 | $6,208,787 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 146,500 | $1,312,640 | 0.88% |